MEME KANSERLİ HASTALARDA CYP19 GENİ KODON 39 Trp/Arg ...

40. Manguoglu AE, Lüleci G, Özçelik T, Çolak T, Schayek H, Akaydın M, Friedman E. Germline
Mutations in the BRCA1 and BRCA2 Genes in Turkish Breast/Ovarian Cancer Patients. Human
Mutation, 2003; 21: 444-451.
41. Yoshida K, Yoshio M. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription and
cell cycle in response to DNA damage. Cancer Science, 2004; 95: 866-871.
42. Rosen EM, Fan S, Pestell RG, Goldberg ID. BRCA1 gene in breast cancer. Journal of Cellular
Physiology, 2003; 196: 19-41.
43. Deng CX. BRCA1:Cell cycle checkpoint, genetic instability, DNA damage response and cancer
evolution. Nucleic Acids Research, 2006; 34:1416-1426.
44. Starita LM, Parvin JD. The multiple nuclear functions of BRCA1: transcription, ubiquitination
and DNA repair. Current Opinion Cell Biology, 2003; 15:345-350.
45. Kristensen VN, Haraldsen EK, Anderson KB, Lonning PE, Erikstein B, Karesen R,
GabrielsenOS, Dale AL. CYP17 and breast cancer risk. 1999; 4:451-459.
46. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Komsa VM, Benhamou S, Kang D,
Vainio H, Uusitupa M, Hirvonen A. Polymorphic Catechol-O-methyltransferase gene and breast
cancer risk. Cancer Epidemiology, 2001; 10:635-640.
47. Mason LF, Sharp L, Cotton SC, Little J. Cytochrome P-450 1A1 Gene Polymorphisms and Risk
of Breast Cancer:A Huge Review. American Journal of Epidemiology, 2005;161:901–915
48. Zheng W, Xie DW, Jin F, Cheng JR, Dai Q, Wen WQ, Shu XO, Gao YT. Genetic Polymorphism of
Cytochrome P450–1B1 and Risk of Breast Cancer. Cancer Epidemiology, 2000; 9:147-150.
49. Millikan R, Pittman G, Tse CK, Savitz DA, Newman B, Bell D. Glutathione S-Transferases M1, T1,
and P1 and Breast Cancer. Cancer Epidemiology, 2000; 9:567-573.
50. Mitrunen K, Sillanpaa P, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Uusitupa M,
Hirvonen A. Association between manganese superoxide dismutase (MnSOD) gene polymorphism
and breast cancer risk. Carcinogenesis, 2001; 22:827-829.
51. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human
nucleated cells. Nucleic Acids Res, 1988; 16(3): 125.
52.
Haiman CA, Hankinson SE, Spiegelman D, De Vivo I, Colditz GA, Willett WC, Speizer FE,
Hunter DJ. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Int J Cancer.,
2000; 15: 204-210.
40